Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Gynecol Oncol. 2012 Feb 12;125(2):451–457. doi: 10.1016/j.ygyno.2012.02.007

Fig. 4.

Fig. 4

A. Six1 protein expression and the survival of patients with high grade serous Stage IIIC Ovarian Cancer. The survival difference is statistically significant (Log Rank p=0.003). B. Six1 mRNA expression from the same patients predicts a survival trend, but is less powerful than protein analysis.